
Osteoarthritis
Phonophoresis of piroxicam significantly reduces pain in mild to moderate knee OA
This report has been verified
by one or more authors of the
original publication.
Arch Phys Med Rehabil. 2013 Feb;94(2):250-5. doi: 10.1016/j.apmr.2012.09.025. Epub 2012 Oct 9
46 patients with mild to moderate knee osteoarthritis were randomized to 2 weeks treatment of either phonophoresis (PhP), using ultrasound and 0.5% piroxicam gel, or to ultrasound treatment alone (UT). The study investigated the effects of phonophoresis in improving knee function and pain, by promoting the absorption of non-steroidal anti-inflammatory drug (NSAID) using an ultra-sound. Post-treatment Visual Analog Scale (VAS) pain and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores significantly reduced in PhP group compared to ultrasound only. Total WOMAC, representing functional improvement, also improved over time, but did not differ between the two groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.